Dyne Therapeutics, Inc. Profile Avatar - Palmy Investing

Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenn…

Biotechnology
US, Waltham [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of DYN's Analysis
CIK: 1818794 CUSIP: 26818M108 ISIN: US26818M1080 LEI: - UEI: -
Secondary Listings
DYN has no secondary listings inside our databases.